Perinodal adipose tissue and fatty acid composition of lymphoid tissues in patients with and without Crohn's disease and their implications for the etiology and treatment of CD

Annals of the New York Academy of Sciences

Volumn 1072, Issue , 2006, Pages 395-400

  Westcott, Edward D A ^a,b,c   Mattacks, Christine A ^c   Windsor, Alastair C J ^b   Knight, Stella C ^a   Pond, Caroline M ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

^c OPEN UNIVERSITY   (United Kingdom)

Author keywords

Arachidonic acid; Lymph nodes; Phospholipids; Site specific properties; Triacylglycerols

Indexed keywords

ARACHIDONIC ACID; DOCOSAHEXAENOIC ACID; FATTY ACID; LINOLEIC ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PALMITIC ACID; POLYUNSATURATED FATTY ACID; TRIACYLGLYCEROL; UNSATURATED FATTY ACID;

ADIPOSE TISSUE; CONFERENCE PAPER; CROHN DISEASE; DIET THERAPY; ELECTIVE SURGERY; EXTRACTION; FATTY ACID ANALYSIS; GAS LIQUID CHROMATOGRAPHY; HUMAN; LIPID COMPOSITION; LYMPHOID CELL; LYMPHOID TISSUE; MAMMAL; MESENTERY LYMPH NODE; QUANTITATIVE ANALYSIS; SYMPTOMATOLOGY; THIN LAYER CHROMATOGRAPHY;

MAMMALIA; RODENTIA;

EID: 33748995690     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1196/annals.1326.034     Document Type: Conference Paper

References (16)

1. POND, C.M. 2003. Paracrine relationships between adipose and lymphoid tissues: implications for the mechanism of HIV-associated adipose redistribution syndrome. Trends Immunol. 24: 13-18.
2. POND, C.M. 2005. Adipose tissue and the immune system. Prostaglandins Leukot. Essent. Fatty Acids 73: 17-30.
3. POND, C.M. & C.A. MATTACKS. 2003. The source of fatty acids incorporated into proliferating lymphoid cells in immune-stimulated lymph nodes. Brit. J. Nutr. 89: 375-382.
4. MATTACKS, C.A. et al. 2004. Site-specific differences in the fatty acid compositions of dendritic cells and associated adipose tissue in popliteal depot, mesentery and omentum, and their modulation by chronic inflammation and dietary lipids. Lymph. Res. Biol. 2: 107-129.
5. MATTACKS, C.A. & C.M. POND. 1997. The effects of feeding suet-enriched chow on site-specific differences in the composition of triacylglycerol fatty acids in adipose tissue and its interactions in vitro with lymphoid cells. Brit. J. Nutr. 77: 621-643.
6. MIURA, S. et al. 1998. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J. Gastroenterol. Hepatol. 13: 1183-1190.
7. CALDER, P.C. 2003. n-3 polyunsaturated fatty acids and inflammation: from molecular biology to the clinic. Lipids 38: 343-352.
8. GEERLING, B.J. et al. 1999. Fat intake and fatty acid profile in plasma phospholipids and adipose tissue in patients with Crohn's disease, compared with controls. Am. J. Gastroenterol. 94: 410-417.
9. TREBBLE, T.M. et al. 2004. Peripheral blood mononuclear cell fatty acid composition and inflammatory mediator production in adult Crohn's disease. Clin. Nutr. 23: 647-655.
10. O'MORAIN, C. et al. 1984. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br. Med. J. 288: 1859-1862.
11. GASSULL, M.A. et al. 2002. Fat composition may be a clue to explain the primary therapeutic effect of enterai nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 51: 164-168.
12. BELLUZZI, A. 2002. n-3 Fatty acids for the treatment of inflammatory bowel diseases. Proc. Nutr. Soc. 61: 391-395.
13. CROHN, B.B. et al. 1932. Regional ileitis, a pathologic and clinical entity. J. Am. Med. Assoc. 99: 1323-1329.
14. SCHAFFLER, A. et al. 2005. Mechanisms of disease: adipocytokines and visceral adipose tissue-emerging role in intestinal and mesenteric diseases. Nat. Clin. Pract. Gastroenterol. Hepatol. 2: 103-111.
15. WESTCOTT, E.D.A. et al. 2005. The fatty acid compositions of lipids in mesenteric adipose tissue and lymphoid cells in patients with and without Crohn's disease and their therapeutic implications. Inflamm. Bowel Dis. 11: 820-827.
16. POND, C.M. 2003. The contribution of wild animal biology to human physiology and medicine. Ecoscience 10: 1-9.